Tert-butyl 3-[[1-(5-bromo-2-pyridinyl)cyclopropyl]carbamoyl]-6,7-dihydro-4H-pyrazolo[1,5-a]pyrazine-5-carboxylate
C20H24BrN5O3 — CID 155255915
Data last refreshed: (MolForge compound catalog, from PubChem)
About Tert-butyl 3-[[1-(5-bromo-2-pyridinyl)cyclopropyl]carbamoyl]-6,7-dihydro-4H-pyrazolo[1,5-a]pyrazine-5-carboxylate
Tert-butyl 3-[[1-(5-bromo-2-pyridinyl)cyclopropyl]carbamoyl]-6,7-dihydro-4H-pyrazolo[1,5-a]pyrazine-5-carboxylate (PubChem CID 155255915) has the molecular formula C20H24BrN5O3 and a molecular weight of 462.35 g/mol. Its IUPAC name is tert-butyl 3-[[1-(5-bromo-2-pyridinyl)cyclopropyl]carbamoyl]-6,7-dihydro-4H-pyrazolo[1,5-a]pyrazine-5-carboxylate.
Molecular Properties
| Compound Name | Tert-butyl 3-[[1-(5-bromo-2-pyridinyl)cyclopropyl]carbamoyl]-6,7-dihydro-4H-pyrazolo[1,5-a]pyrazine-5-carboxylate |
|---|---|
| PubChem CID | 155255915 |
| Molecular Formula | C20H24BrN5O3 |
| Molecular Weight | 462.35 g/mol |
| Exact Mass | 461.11 |
| IUPAC Name | tert-butyl 3-[[1-(5-bromo-2-pyridinyl)cyclopropyl]carbamoyl]-6,7-dihydro-4H-pyrazolo[1,5-a]pyrazine-5-carboxylate |
| SMILES | CC(C)(C)OC(=O)N1CCn2ncc(C(=O)NC3(c4ccc(Br)cn4)CC3)c2C1 |
| InChI | InChI=1S/C20H24BrN5O3/c1-19(2,3)29-18(28)25-8-9-26-15(12-25)14(11-23-26)17(27)24-20(6-7-20)16-5-4-13(21)10-22-16/h4-5,10-11H,6-9,12H2,1-3H3,(H,24,27) |
| InChIKey | OOZUNGRMGWKJHX-UHFFFAOYSA-N |
| XLogP | 3.21 |
| TPSA | 89.35 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 3 |
| Heavy Atoms | 29 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 462.35 |
| LogP ≤ 5 | 3.21 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 6 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 155255915 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.